O

Opthea Limited

D
OPT
USD
-0.126
(-3.0172%)
Market Closed
500.00
حجم التداول
-2.32912
الربح لكل سهم
-
العائد الربحي
-1.466966
P/E
623,241,649.35
حجم السوق
اليوم
-3.0172%
1 اسبوع
-7.534%
1 شهر
-13.090%
6 اشهر
14.085%
12 اشهر
134.104%
بداية السنة
35.452%
كل الوقت
0%

Title:
Opthea Limited

Sector:
Healthcare
Industry:
Biotechnology
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
هل تحتاج مساعدة او لديك استفسار؟